We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Bright Salon is a smartphone app that is designed to allow hair and beauty salons grow their business. The app can be used to fill in the gaps from last minute cancellations. The app can also be used as an alternative to paper-based loyalty schemes. Using the app for a loyalty scheme allows customers to see exactly how many points they have and the milestones they have to reach to acheive certain rewards.
days to go: Expired investment: £28,640
My Friends Room allows travellers to rent accommodation from friends and friends of friends. Many vacation rentals can seem unsafe and impersonal. However renting from a friend or someone that has been recommended from a friend prevents this feeling of unsafety.
days to go: Expired investment: £97,870
Ofixu is an online platform that ai mto help you with your office requirements. If you have underutilised space then Ofixu will help you earn extra cash by listing it at no extra cost. On the other hand, if you're an entrepreneur looking to rent an office, you can find one local to you by using Ofixu's worldwide search function. 
days to go: Expired investment: £52,412
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £215,946
Triple Tread is a tricycle that has been designed for people who lack the balance to ride a bicycle or that have neurological illnesses such as MS and are therefore unable to ride a bicycle. The Triple Tread was designed to look similar to standard bicycles and uses many standard components.
days to go: Expired investment: £10,770
Housebooker offers holiday accommodation in real peoples homes. They provide its clients with a way of generating a significant income through their managed services and aim to achieve a better return for their clients over what they would traditionally get from a buy-to-let. 
days to go: Expired investment: £12,950
The Highland Motorcycle Company is the vision of a 'one stop, all needs catered for' focal point for the motorcycle community of the Scottish Highlands. We intend to establish ourselves as the local motorcycle destination.
days to go: Expired investment: £61,550
Alyve provides personalised subscription nutrition powered by Artificial Intelligence (AI). It argues that 8.2 million UK vitamin users are looking for personalised nutrition in one capsule. Alyve asserts that its product can fulfil this demand. Users complete a 3-minute questionnaire where their responses are recorded by Alyve's intelligent algorithms. These then, based on the responses, help the user select one of Alyve's nutritional pills best matched to their goals and needs. Alyve then delivers the pills to the user's doorstep every 30 days. The company has recorded 4000+ questionnaires and completed 800+ orders in 25 countries since Q4 of 2020. It aims to become a contender in the $21 billion supplement market. The company will use the investment received to increase marketing efforts, transform Alyve into a household brand, introduce new product lines, increase staff, improve technology, and transform both digital and physical User Experiences (UX).

Pitch Rated

80%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £227,782
Uproot is an e-commerce platform that offers a diverse selection of organic and sustainable products. Born from reflections during the pandemic, it challenges the superficial pursuits driven by societal pressures. Uproot questions the effects of consumerism on our lives and the environment, aiming to establish a space where mindful choices and natural goodness thrive. By uniting a community of individuals dedicated to positive transformation, Uproot seeks to align human existence with the planet, promoting renewal and revitalization for both people and the Earth.
days to go: Expired investment: Withheld
BioScore is a London-based health technology platform that enables you to easily visualize, track, and understand your fitness and health test results. It is currently designed as a software service for health and fitness professionals, gyms, personal trainers, sports coaches, sports clubs, schools, other allied health consultants and their clients. Leveraging on the trend of health optimization, BioScore aims to provide meaningful infographics and explanations, linked test histories, and personalised advice and action plans from fitness or health experts to their respective end-users, resulting in more effective diagnosis of ailments. The company will utilise the investment to develop an athlete management platform with an inspiring infographic, reporting and sell licences to access the platform's suite of online tools.

Pitch Rated

63%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £57,580
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph